Maravai Lifesciences Holdings (MRVI) Cash from Investing Activities (2020 - 2026)

Maravai Lifesciences Holdings' Cash from Investing Activities history runs 7 years deep, the most recent figure standing at -$4.4 million for Q1 2026.

• In Q1 2026, Cash from Investing Activities rose 80.82% year-over-year to -$4.4 million; the TTM figure through Mar 2026 stood at -$12.7 million (up 70.57% YoY), while the FY2025 annual figure was -$31.4 million, down 29.15% from the prior year.
• Cash from Investing Activities for Q1 2026 stood at -$4.4 million, down from -$2.1 million in the prior quarter.
• The five-year high for Cash from Investing Activities was -$1.7 million in Q2 2022, with the low at -$241.6 million in Q1 2022.
• The 5-year median for Cash from Investing Activities is -$6.2 million (2024), against an average of -$26.5 million.
• The sharpest annual moves came in 2022 and 2024: Cash from Investing Activities plunged 8577.59% in 2022, then surged 93.91% in 2024.
• Maravai Lifesciences Holdings' Cash from Investing Activities stood at -$18.5 million in 2022, then jumped by 30.33% to -$12.9 million in 2023, then jumped by 61.78% to -$4.9 million in 2024, then surged by 57.13% to -$2.1 million in 2025, then plunged by 109.89% to -$4.4 million in 2026.
• Business Quant data shows MRVI's Cash from Investing Activities at -$4.4 million in Q1 2026, -$2.1 million in Q4 2025, and -$2.9 million in Q3 2025.